• Je něco špatně v tomto záznamu ?

The effects of cerebral oximetry in mechanically ventilated newborns: a protocol for the SafeBoosC-IIIv randomised clinical trial

ML. Vestager, ML. Hansen, MI. Rasmussen, GH. Hahn, S. Hyttel-Sørensen, A. Pellicer, AM. Heuchan, C. Hagmann, E. Dempsey, G. Dimitriou, G. Pichler, G. Naulaers, H. Fuchs, J. Tkaczyk, J. Mintzer, M. Fumagalli, S. Nesargi, S. Fredly, T. Szczapa, C....

. 2023 ; 24 (1) : 696. [pub] 20231028

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu protokol klinické studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24000968

BACKGROUND: The SafeBoosC project aims to test the clinical value of non-invasive cerebral oximetry by near-infrared spectroscopy in newborn infants. The purpose is to establish whether cerebral oximetry can be used to save newborn infants' lives and brains or not. Newborns contribute heavily to total childhood mortality and neonatal brain damage is the cause of a large part of handicaps such as cerebral palsy. The objective of the SafeBoosC-IIIv trial is to evaluate the benefits and harms of cerebral oximetry added to usual care versus usual care in mechanically ventilated newborns. METHODS/DESIGN: SafeBoosC-IIIv is an investigator-initiated, multinational, randomised, pragmatic phase-III clinical trial. The inclusion criteria will be newborns with a gestational age more than 28 + 0 weeks, postnatal age less than 28 days, predicted to require mechanical ventilation for at least 24 h, and prior informed consent from the parents or deferred consent or absence of opt-out. The exclusion criteria will be no available cerebral oximeter, suspicion of or confirmed brain injury or disorder, or congenital heart disease likely to require surgery. A total of 3000 participants will be randomised in 60 neonatal intensive care units from 16 countries, in a 1:1 allocation ratio to cerebral oximetry versus usual care. Participants in the cerebral oximetry group will undergo cerebral oximetry monitoring during mechanical ventilation in the neonatal intensive care unit for as long as deemed useful by the treating physician or until 28 days of life. The participants in the cerebral oximetry group will be treated according to the SafeBoosC treatment guideline. Participants in the usual care group will not receive cerebral oximetry and will receive usual care. We use two co-primary outcomes: (1) a composite of death from any cause or moderate to severe neurodevelopmental disability at 2 years of corrected age and (2) the non-verbal cognitive score of the Parent Report of Children's Abilities-Revised (PARCA-R) at 2 years of corrected age. DISCUSSION: There is need for a randomised clinical trial to evaluate cerebral oximetry added to usual care versus usual care in mechanically ventilated newborns. TRIAL REGISTRATION: The protocol is registered at www. CLINICALTRIALS: gov (NCT05907317; registered 18 June 2023).

2 Department of Neonatology Neonatal Biophysical Monitoring and Cardiopulmonary Therapies Research Unit Poznan University of Medical Sciences Poznan Poland

Copenhagen Trial Unit Centre for Clinical Intervention Research The Capital Region Copenhagen University Hospital ─ Rigshospitalet Copenhagen Denmark

Department of Clinical Sciences and Community Health University of Milan Milan Italy

Department of Intensive Care Copenhagen University Hospital Rigshospitalet Copenhagen Denmark

Department of Neonatology Children's University Hospital of Zürich Zurich Switzerland

Department of Neonatology Copenhagen University Hospital ─ Rigshospitalet Copenhagen Denmark

Department of Neonatology La Paz University Hospital Madrid Spain

Department of Neonatology Oslo University Hospital Oslo Norway

Department of Neonatology Royal Hospital for Children Glasgow UK

Department of Neonatology University Hospital Leuven Louvain Belgium

Department of Neonatology University Hospital Motol Prague Czech Republic

Department of Pediatrics Medical University of Graz Graz Austria

Department of Regional Health Research The Faculty of Health Sciences University of Southern Denmark Odense Denmark

Division of Neonatology and Pediatric Intensive Care Medicine Center for Pediatrics and Adolescents Medicine Medical Center ─ University of Freiburg Freiburg Germany

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Milan Italy

Infant Centre and Department of Paediatrics and Child Health University College Cork Cork Ireland

NICU Department of Paediatrics University General Hospital of Patras Patras Greece

St Johns Medical College Hospital Bengaluru India

The Department of Pediatrics Division of Newborn Medicine Mountainside Medical Center Montclair NJ USA

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24000968
003      
CZ-PrNML
005      
20240213093530.0
007      
ta
008      
240109s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13063-023-07699-x $2 doi
035    __
$a (PubMed)37898759
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Vestager, Maria Linander $u Department of Neonatology, Copenhagen University Hospital ─ Rigshospitalet, Copenhagen, Denmark. maria.linander.vestager@regionh.dk $1 https://orcid.org/0000000232730791
245    14
$a The effects of cerebral oximetry in mechanically ventilated newborns: a protocol for the SafeBoosC-IIIv randomised clinical trial / $c ML. Vestager, ML. Hansen, MI. Rasmussen, GH. Hahn, S. Hyttel-Sørensen, A. Pellicer, AM. Heuchan, C. Hagmann, E. Dempsey, G. Dimitriou, G. Pichler, G. Naulaers, H. Fuchs, J. Tkaczyk, J. Mintzer, M. Fumagalli, S. Nesargi, S. Fredly, T. Szczapa, C. Gluud, JC. Jakobsen, G. Greisen
520    9_
$a BACKGROUND: The SafeBoosC project aims to test the clinical value of non-invasive cerebral oximetry by near-infrared spectroscopy in newborn infants. The purpose is to establish whether cerebral oximetry can be used to save newborn infants' lives and brains or not. Newborns contribute heavily to total childhood mortality and neonatal brain damage is the cause of a large part of handicaps such as cerebral palsy. The objective of the SafeBoosC-IIIv trial is to evaluate the benefits and harms of cerebral oximetry added to usual care versus usual care in mechanically ventilated newborns. METHODS/DESIGN: SafeBoosC-IIIv is an investigator-initiated, multinational, randomised, pragmatic phase-III clinical trial. The inclusion criteria will be newborns with a gestational age more than 28 + 0 weeks, postnatal age less than 28 days, predicted to require mechanical ventilation for at least 24 h, and prior informed consent from the parents or deferred consent or absence of opt-out. The exclusion criteria will be no available cerebral oximeter, suspicion of or confirmed brain injury or disorder, or congenital heart disease likely to require surgery. A total of 3000 participants will be randomised in 60 neonatal intensive care units from 16 countries, in a 1:1 allocation ratio to cerebral oximetry versus usual care. Participants in the cerebral oximetry group will undergo cerebral oximetry monitoring during mechanical ventilation in the neonatal intensive care unit for as long as deemed useful by the treating physician or until 28 days of life. The participants in the cerebral oximetry group will be treated according to the SafeBoosC treatment guideline. Participants in the usual care group will not receive cerebral oximetry and will receive usual care. We use two co-primary outcomes: (1) a composite of death from any cause or moderate to severe neurodevelopmental disability at 2 years of corrected age and (2) the non-verbal cognitive score of the Parent Report of Children's Abilities-Revised (PARCA-R) at 2 years of corrected age. DISCUSSION: There is need for a randomised clinical trial to evaluate cerebral oximetry added to usual care versus usual care in mechanically ventilated newborns. TRIAL REGISTRATION: The protocol is registered at www. CLINICALTRIALS: gov (NCT05907317; registered 18 June 2023).
650    _2
$a kojenec $7 D007223
650    _2
$a dítě $7 D002648
650    _2
$a novorozenec $7 D007231
650    _2
$a lidé $7 D006801
650    12
$a oxymetrie $x metody $7 D010092
650    12
$a umělé dýchání $x škodlivé účinky $7 D012121
650    _2
$a mozkový krevní oběh $7 D002560
650    _2
$a mozek $7 D001921
650    _2
$a jednotky intenzivní péče o novorozence $7 D007363
650    _2
$a randomizované kontrolované studie jako téma $7 D016032
655    _2
$a protokol klinické studie $7 D000078325
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hansen, Mathias Lühr $u Department of Neonatology, Copenhagen University Hospital ─ Rigshospitalet, Copenhagen, Denmark $u Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital ─ Rigshospitalet, Copenhagen, Denmark
700    1_
$a Rasmussen, Marie Isabel $u Department of Neonatology, Copenhagen University Hospital ─ Rigshospitalet, Copenhagen, Denmark
700    1_
$a Hahn, Gitte Holst $u Department of Neonatology, Copenhagen University Hospital ─ Rigshospitalet, Copenhagen, Denmark
700    1_
$a Hyttel-Sørensen, Simon $u Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
700    1_
$a Pellicer, Adelina $u Department of Neonatology, La Paz University Hospital, Madrid, Spain
700    1_
$a Heuchan, Anne Marie $u Department of Neonatology, Royal Hospital for Children, Glasgow, UK
700    1_
$a Hagmann, Cornelia $u Department of Neonatology, Children's University Hospital of Zürich, Zurich, Switzerland
700    1_
$a Dempsey, Eugene $u Infant Centre and Department of Paediatrics and Child Health, University College Cork, Cork, Ireland
700    1_
$a Dimitriou, Gabriel $u NICU, Department of Paediatrics, University General Hospital of Patras, Patras, Greece
700    1_
$a Pichler, Gerhard $u Department of Pediatrics, Medical University of Graz, Graz, Austria
700    1_
$a Naulaers, Gunnar $u Department of Neonatology, University Hospital Leuven, Louvain, Belgium
700    1_
$a Fuchs, Hans $u Division of Neonatology and Pediatric Intensive Care Medicine, Center for Pediatrics and Adolescents Medicine, Medical Center ─ University of Freiburg, Freiburg, Germany
700    1_
$a Tkaczyk, Jakub $u Department of Neonatology, University Hospital Motol, Prague, Czech Republic
700    1_
$a Mintzer, Jonathan $u The Department of Pediatrics, Division of Newborn Medicine, Mountainside Medical Center, Montclair, NJ, USA
700    1_
$a Fumagalli, Monica $u Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, Italy $u Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
700    1_
$a Nesargi, Saudamini $u St. Johns Medical College Hospital, Bengaluru, India
700    1_
$a Fredly, Siv $u Department of Neonatology, Oslo University Hospital, Oslo, Norway
700    1_
$a Szczapa, Tomasz $u II Department of Neonatology, Neonatal Biophysical Monitoring and Cardiopulmonary Therapies Research Unit, Poznan University of Medical Sciences, Poznan, Poland
700    1_
$a Gluud, Christian $u Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital ─ Rigshospitalet, Copenhagen, Denmark $u Department of Regional Health Research, The Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark
700    1_
$a Jakobsen, Janus Christian $u Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital ─ Rigshospitalet, Copenhagen, Denmark $u Department of Regional Health Research, The Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark
700    1_
$a Greisen, Gorm $u Department of Neonatology, Copenhagen University Hospital ─ Rigshospitalet, Copenhagen, Denmark
773    0_
$w MED00163187 $t Trials $x 1745-6215 $g Roč. 24, č. 1 (2023), s. 696
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37898759 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213093527 $b ABA008
999    __
$a ok $b bmc $g 2049539 $s 1210662
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 24 $c 1 $d 696 $e 20231028 $i 1745-6215 $m Trials $n Trials $x MED00163187
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Možnosti archivace